Tag

Dr. Yasir Rawjee

2 articles

Alivus Life Sciences Q2 FY27 Revenue Up 16% YoY

Alivus Life Sciences reported Q2 FY27 revenue of ₹6,820 Mn, a 16.0% YoY growth, driven by strong non-GPL business and CDMO growth. PAT surged 51.3% YoY to ₹1,968 Mn, with margins expanding significant

Alivus Q2 Revenue Up 16%, EBITDA Margin 41.8%

Alivus Life Sciences reported Q2FY27 revenue of Rs. 6,820 Mn, up 16.0% YoY, driven by 20.8% growth in non-GPL business. EBITDA surged 47.0% YoY to Rs. 2,851 Mn with record margins of 41.8%, up 880 bps